Gala
 

Bloom Burton & Co. Announces the Inaugural Bloom Burton Award Gala

Annual Award to Recognize the Most Significant Contributor to Canada’s Healthcare Industry
 

Tickets will be on sale shortly
TORONTO, January 6, 2017 – Bloom Burton & Co. (“Bloom Burton”), Canada’s leading healthcare-specialized investment banking firm, is thrilled to introduce the inaugural Bloom Burton Award Gala that will be held at the Four Seasons Hotel in Toronto, Ontario, Canada on September 14, 2017.

Bestowed annually, the Bloom Burton Award will honour an individual scientist, inventor, executive, entrepreneur, industry leader, or policy maker who made the greatest impact in Canada’s innovative healthcare industry. Nominees will be accepted from the biotechnology, pharmaceutical, medical device, diagnostic/imaging, research instrumentation, consumer health, healthcare services or healthcare IT sectors, and from all therapeutic indications and stages of development.

The Bloom Burton Award winner will be chosen by an esteemed panel of judges, all of whom are respected international leaders in healthcare investment, entrepreneurship and journalism. The panel includes:

    • Karen Bernstein, Co-Founder and Chairman, BioCentury Inc.
    • Terrence Connolly, Executive Director, Global Alliances and Business Development, Celgene Corporation
    • Carl Gordon, Partner and Co-Head of Global Private Equity, OrbiMed Advisors
    • Andrew Hack, Chief Financial Officer, Editas Medicine
    • Oleg Nodelman, Founder and Managing Director, EcoR1 Capital
    • Melinda Richter, Head of Johnson & Johnson Innovation, JLABS
    • Avik Roy, Opinion Editor, Forbes; President, The Foundation for Research and Equal Opportunity

Nominations may be submitted by the public at large on or before March 31, 2017. A narrowed list of three finalists will be announced at the Bloom Burton & Co. Healthcare Investor Conference, May 1-2, 2017. All three finalists, along with their family and friends, will be invited to and celebrated at the Bloom Burton Award Gala on September 14, 2017. The winner will receive a $50,000 cash prize, while the other two finalists will each receive $25,000. A limited number of tickets are available for industry sponsors and individuals.

Brian Bloom, President of Bloom Burton & Co. commented, “It’s time to celebrate those who advance medical science, attract and provide risk capital, launch new products and companies on the world stage or announce significant monetization events. The Bloom Burton Award will celebrate today’s finest, who have made a significant impact – and there will be recognition for this contribution in the year it was achieved.”

Kindly send single page nomination letters to:

Erika Agnew
Event Coordinator
Tel: (416) 640-7575
eagnew(at)bloomburton.com

For table sponsorship and other inquiries:

Brian Bloom
President
Tel: (416) 640-7580
bbloom(at)bloomburton.com

About Bloom Burton & Co.:

Bloom Burton & Co. is a firm dedicated to accelerating returns in the healthcare sector for both investors and companies. Bloom Burton has an experienced team of medical, scientific, pharmaceutical, legal and capital markets professionals who perform a deep level of diligence, which combined with our creative and entrepreneurial approach, assists our clients in achieving the right monetization events. Bloom Burton and its affiliates provide capital raising, M&A advisory, equity research, business strategy and scientific consulting, advisory on direct investing and company creation and incubation services. Bloom Burton Securities Inc. is a member of the Investment Industry Regulatory Organization of Canada (IIROC) and is also a member of the Canadian Investor Protection Fund (CIPF). Please visit www.bloomburton.com to learn more.